Skip to main content

Table 4 Service utilisation and CVD management for participants with and without a GPMP in the 24 months preceding RCT enrolment

From: Utilisation of government-subsidised chronic disease management plans and cardiovascular care in Australian general practices

 

With a GPMP

(N = 422)

Without a GPMP

(N = 483)

Total

(N = 905)

Service Provision

 Number of GP appointments (median (IQR))

19.0 (12.0, 27.0)

12.0 (8.0, 17.0)

14.0 (10.0, 22.0)

 Seen by a practice nurse

112/422 (26.5%)

14/483 (2.9%)

126/905 (13.9%)

 At least one specialist consultation

389/422 (92.2%)

399/483 (82.6%)

788/905 (87.1%)

MBS Items Claimed

 Health assessment

81/422 (19.2%)

23/483 (4.8%)

104/905 (11.5%)

 Team Care Arrangement

380/422 (90.0%)

3/483 (0.6%)

383/905 (42.3%)

 Mental Health Management Plan

35/422 (8.3%)

26/483 (5.4%)

61/905 (6.7%)

 Review of GPMP/TCA

166/422 (39.3%)

27/483 (5.6%)

193/905 (21.3%)

 Mental Health Consultation

35/422 (8.3%)

13/483 (2.7%)

48/905 (5.3%)

 Medication review

11/422 (2.6%)

6/483 (1.2%)

17/905 (1.9%)

MBS-subsidised Allied Health Professional Visits (at least once)

 Diabetes educator

1/422 (0.2%)

0/483(0.0%)

1/905 (0.1%)

 Dietitian

49/422 (11.6%)

13/483 (2.7%)

62/905 (6.9%)

 Exercise physiologist

29/422 (6.9%)

2/483 (0.4%)

31/905 (3.4%)

 Podiatrist

158/422 (37.4%)

15/483 (3.1%)

173/905 (19.1%)

 Physiotherapist

111/422 (26.3%)

19/483 (3.9%)

130/905 (14.4%)

 Psychologist

17/422 (4.0%)

17/483 (3.5%)

34/905 (3.8%)

 Any of the above

293/422 (69.4%)

56/483 (11.6%)

349/905 (38.6%)

Guideline Recommended Medication Use (self-report or PDC last 12 months)

 BP-lowering (self-report)a

268/422 (63.5%)

248/483 (51.3%)

516/905 (57.0%)

 BP-lowering (prescription data)b

251/422 (59.5%)

221/483 (45.8%)

472/905 (52.2%)

 Lipid-lowering (self-report)a

240/422 (56.9%)

225/483 (46.6%)

465/905 (51.4%)

 Lipid-lowering (prescription data)b

190/422 (45.0%)

150/483 (31.1%)

340/905 (37.6%)

 Combined BP and lipid-lowering (prescription data)

149/422 (35.3%)

106/483 (21.9%)

255/905 (28.2%)

Meeting Clinical Targets

 BPc

169/422 (40.0%)

179/483 (37.1%)

348/905 (38.5%)

 LDLd

148/422 (35.1%)

104/483 (21.5%)

252/905 (27.8%)

 Both BP and LDL targets met

63/422 (14.9%)

36/483 (7.5%)

99/905 (10.9%)

  1. aDefined as taking the medication for five or more of the previous seven days
  2. bDefined as PDC of ≥ 80% based on pharmacy dispensing data
  3. c Defined as ≤ 130/80 mmHg for people with CVD, diabetes or albuminuria and ≤ 140/90 mmHg for all others
  4. LDL-cholesterol < 2.0 mmol/l
  5. Abbreviations: BP Blood pressure, GP General practice, GPMP General practice management plan, IQR Interquartile range, LDL Low density lipoprotein, PBS Pharmaceutical Benefits Scheme, PDC Proportion of days covered